-
Transplantation for severe OSD
Monday, March 1, 2021Cultivated oral mucosal epithelial transplantation (COMET) is a very effective surgical modality that avoids graft rejection and complications when treating patients with severe ocular surface diseases
-
Anomalies in the optic nerve
Monday, March 1, 2021There are five important congenital hereditary and non-hereditary optic nerve anomalies that require early diagnosis in order to preserve and enhance vision
-
Amblyopia: a binocular disorder
Monday, February 1, 2021Computer games and other treatments employing a binocular approach may provide better outcomes than patching in terms of visual acuity of the affected eye, while also mildly enhancing stereoacuity and reducing interocular suppression in amblyopia patients
-
Infant aphakia treatment
Monday, February 1, 2021The landmark infant aphakia treatment study (IATS) showed that aphakia is safe in very young infants
-
Artisan IOLs in the paediatric population
Monday, February 1, 2021The Artisan (Ophtec) iris-fixated intraocular lens appears to be a safe and effective option for the refractive correction of aphakia in children with insufficient capsular support
-
Secondary IOLs in children: now or later?
Monday, February 1, 2021Delaying intraocular lens (IOL) implantation in children with congenital cataracts until refraction has stabilised can provide a better refractive outcome than primary surgery
-
Infectious keratitis in children
Thursday, December 3, 2020Paediatric microbial keratitis requires special diagnostic considerations
-
Endothelial keratoplasty in children
Thursday, December 3, 2020Paediatric keratoplasty possesses several distinct challenges in comparison to adults
-
Paediatric PK precautions
Monday, November 2, 2020Penetrating keratoplasty is extremely challenging in a paediatric patient population, but favourable outcomes may still be obtained with careful case selection, rigorous surgical technique and meticulous postoperative care
-
Amblyopia treatment evidence
Monday, November 2, 2020Spectacles, patching and atropine have strong evidence as effective treatments for amblyopia, whereas many other treatments must be regarded with a degree of scepticism until they have been studied in rigorous randomised controlled trials
